About this trial
This study aims to establish a large sample cohort of patients with primary sjogren's syndrome, collect multi-omics information of patients with primary sjogren's syndrome, and construct disease diagnosis model and disease prognosis prediction model.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Meets the 2002 AECG or 2016 ACR/EULAR classification criteria of primary Sjögren's syndrome.
Disqualifiers
Comorbid connective tissue disease other than the disease under research.
Women who are pregnant or breastfeeding.
Combined severe cardiovascular or cerebrovascular disease, hepatic or renal failure, or severe malignant tumors.
Other conditions (e.g., cognitive impairment) that the investigators consider ineligible for enrollment.
Trial population
Patients with primary Sjögren's syndrome
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Number of participants with system involvement
System involvement determined from clinical diagnosis
Secondary outcomes
Mortality
All-cause mortality
Number of participants with tumor
Tumor determined from clinical diagnosis
Number of participants with connective tissue disease
Connective tissue disease determined from clinical diagnosis
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
China-Japan Friendship Hospital
Lead sponsor
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Collaborator
Beijing Hospital of Traditional Chinese Medicine
Collaborator
Shunyi Hospital, Beijing Traditional Chinese Medicine Hospital
Collaborator